Looking for a new broker?
Virtus LifeSci Biotech Clinical Trials ETF stock is up 6.11% since 30 days ago. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 9 December’s closed higher than November.
N/A
